X0306 4 2020-05-12 0001682852 Moderna, Inc. MRNA 0001690927 Zaks Tal Zvi C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Medical Officer Common Stock 2020-05-12 4 M 0 125044 12.21 A 125044 D Common Stock 2020-05-12 4 S 0 300 67.23 D 124744 D Common Stock 2020-05-12 4 S 0 1365 66.43 D 123379 D Common Stock 2020-05-12 4 S 0 25905 65.46 D 97474 D Common Stock 2020-05-12 4 S 0 59913 64.72 D 37561 D Common Stock 2020-05-12 4 S 0 19817 63.59 D 17744 D Common Stock 2020-05-12 4 S 0 17744 62.65 D 0 D Stock Option (Right to Buy) 12.21 2020-05-12 4 M 0 125044 0 D 2027-02-23 Common Stock 125044 58442 D This sale was effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.16 to $67.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.13 to $67.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.12 to $66.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.11 to $65.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.10 to $64.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.09 to $63.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. /s/ Lori Henderson, as Attorney-in-Fact 2020-05-14